1. Humbert, M, Guignabert, C, Bonnet, S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J 2019; 53: 1–14.
Google Scholar | Crossref2. Benza, RL, Miller, DP, Barst, RJ, et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest 2012; 142: 448–456.
Google Scholar | Crossref | Medline | ISI3. Thenappan, T, Shah, SJ, Rich, S, et al. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010; 35: 1079–1087.
Google Scholar | Crossref | Medline | ISI4. Shi, M, Liu, ZW, Wang, FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 2011; 164: 1–8.
Google Scholar | Crossref | Medline | ISI5. Gebler, A, Zabel, O, Seliger, B. The immunomodulatory capacity of mesenchymal stem cells. Trends Mol Med 2012; 18: 128–134.
Google Scholar | Crossref6. Li, T, Wu, Y. Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche. Bone Marrow Res 2011; 2011: 353878.
Google Scholar | Crossref | Medline7. da Silva, CL, Goncalves, R, dos Santos, F, et al. Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38− and early lymphoid CD7+ cells. J Tissue Eng Regen Med 2010; 4: 149–158.
Google Scholar | Crossref8. Bernardo, ME, Fibbe, WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 2013; 13: 392–402.
Google Scholar | Crossref | Medline | ISI9. Kanki-Horimoto, S, Horimoto, H, Mieno, S, et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 2006; 114: I181–I185.
Google Scholar | Crossref | Medline | ISI10. Aliotta, JM, Keaney, PJ, Warburton, RR, et al. Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension. Stem Cells Dev 2009; 18: 773–782.
Google Scholar | Crossref11. Chen, CM, Lin, W, Huang, LT, et al. Human mesenchymal stem cells ameliorate experimental pulmonary hypertension induced by maternal inflammation and neonatal hyperoxia in rats. Oncotarget 2017; 8: 82366–82375.
Google Scholar | Crossref | Medline12. de Mendonca, L, Felix, NS, Blanco, NG, et al. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension. Stem Cell Res Ther 2017; 8: 220.
Google Scholar | Crossref | Medline13. Alencar, AKN, Pimentel-Coelho, PM, Montes, GC, et al. Human mesenchymal stem cell therapy reverses Su5416/hypoxia-induced pulmonary arterial hypertension in mice. Front Pharmacol 2018; 9: 1395.
Google Scholar | Crossref | Medline14. Liang, OD, Mitsialis, SA, Chang, MS, et al. Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension. Stem Cells 2011; 29: 99–107.
Google Scholar | Crossref | Medline | ISI15. Meldolesi, J. Exosomes and ectosomes in intercellular communication. Curr Biol 2018; 28: R435–R444.
Google Scholar | Crossref | Medline16. Paolicelli, RC, Bergamini, G and, Rajendran, L. Cell-to-cell communication by extracellular vesicles: focus on microglia. Neuroscience 2019; 405: 148–157.
Google Scholar | Crossref17. Maia, J, Caja, S, Strano Moraes, MC, et al. Exosome-based cell-cell communication in the tumor microenvironment. Front Cell Dev Biol 2018; 6: 18.
Google Scholar | Crossref | Medline18. van der Vorst, EPC, de Jong, RJ and, Donners, M. Message in a microbottle: modulation of vascular inflammation and atherosclerosis by extracellular vesicles. Front Cardiovasc Med 2018; 5: 2.
Google Scholar | Crossref | Medline19. Phinney, DG, Di Giuseppe, M, Njah, J, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun 2015; 6: 8472.
Google Scholar | Crossref | Medline20. Morrison, TJ, Jackson, MV, Cunningham, EK, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med 2017; 196: 1275–1286.
Google Scholar | Crossref21. Willis, GR, Fernandez-Gonzalez, A, Anastas, J, et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am J Respir Crit Care Med 2018; 197: 104–116.
Google Scholar | Crossref | Medline22. Klinger, JR, Pereira, M, Del Tatto, M, et al. Mesenchymal stem cell extracellular vesicles reverse Sugen/hypoxia pulmonary hypertension in rats. Am J Respir Cell Mol Biol 2020; 62: 577–587.
Google Scholar | Crossref | Medline23. Lee, C, Mitsialis, SA, Aslam, M, et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012; 126: 2601–2611.
Google Scholar | Crossref | Medline | ISI24. Hogan, SE, Rodriguez Salazar, MP, Cheadle, J, et al. Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2019; 316: L723–L737.
Google Scholar | Crossref | Medline25. Collino, F, Lopes, JA, Correa, S, et al. Adipose-derived mesenchymal stromal cells under hypoxia: changes in extracellular vesicles secretion and improvement of renal recovery after ischemic injury. Cell Physiol Biochem 2019; 52: 1463–1483.
Google Scholar | Medline26. Lo Sicco, C, Reverberi, D, Balbi, C, et al. Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization. Stem Cells Transl Med 2017; 6: 1018–1028.
Google Scholar | Crossref | Medline27. Aliotta, JM, Pereira, M, Wen, S, et al. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice. Cardiovasc Res 2016; 110: 319–330.
Google Scholar | Crossref | Medline | ISI28. Wen, S, Dooner, M, Cheng, Y, et al. Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia 2016; 30: 2221–2231.
Google Scholar | Crossref | Medline29. Chen, JY, An, R, Liu, ZJ, et al. Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats. Acta Pharmacol Sin 2014; 35: 1121–1128.
Google Scholar | Crossref | Medline30. Liu, Z, Liu, J, Xiao, M, et al. Mesenchymal stem cell-derived microvesicles alleviate pulmonary arterial hypertension by regulating renin-angiotensin system. J Am Soc Hypertens 2018; 12: 470–478.
Google Scholar | Crossref | Medline31. Zhang, Z, Ge, L, Zhang, S, et al. The protective effects of MSC-EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway. J Cell Mol Med 2020; 24: 13938–13948.
Google Scholar | Crossref | Medline